FDA approves Mylan epilepsy drug

PITTSBURGH — The Food and Drug Administration has approved a drug for epilepsy made by Mylan, the drug maker said.



The FDA approved Mylan's levetiracetam extended-release tablets in the 500-mg and 750-mg strengths.



The drug is a generic version of UCB's Keppra XR, used to treat partial onset seizures in epilepsy patients ages 16 years and older.



Various versions of the drug had sales of about $162.8 million during the 12-month period ended in September, according to IMS Health.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.